Multimodal imaging (e.g. MRI and optical imaging) with targeted nanoparticle based magneto-optical probes allows for detection of a broad range of molecular-cellular targets through their modular design. Here, we propose the construction multimodal probes addressing mVCAM-1 expression on endothelial cells as response to inflammatory factors. Targeted multimodal nanoparticle probes were designed consisting of 3 components: an iron oxide core derivatized with dextran (with and without PEG-linker), antibodies directed to the cell-surface molecule VCAM-1, and a nearinfrared fluorochrome (DY-649). Physicochemical and cell-binding properties of the probes were evaluated on murine endothelial cells. After the conjugation of anti-VCAM-1 antibody/DY-649 constructs (2.2 -3.1 nmol antibody/mg Fe and 2.6 -4.6 nmol DY-649/mg Fe) to the magnetic nanoparticles, the hydrodynamic diameters of the nanoparticles increased slightly. No aggregations of the probes were detectable, their corresponding relaxivities were r1 = 7.8 -8.4 1/mM/s, r2 = 180 -325 1/mM/s and r2* = 274 -348 1/mM/s. Using optical imaging, the VCAM-1 targeted magneto-optical probes gave detectable fluorescence signals after binding to murine endothelial cells, the signals decreased by blocking with unlabelled anti-mVCAM-1 antibodies. This observation demonstrates the specific binding properties of the designed VCAM-1 specific bimodal nanoparticle based probes. We showed that it is possible to produce multimodal magnetic nanoparticles selectively addressing mVCAM-1 on endothelial cells by conjugation of DY-649-labelled antibodies to magnetic nanoparticles. Our probes exhibit good capabilities to be used as a probe in multimodal imaging approaches of diseases with increased mVCAM-1-expression (e.g. inflammation) with MRI and optical imaging in murine animal models.
Introduction
Detection of diseases with non-invasive imaging approaches before pathophysiological changes occur is the principal aim of the molecular imaging research field. Important steps for the clinical translation of molecular imaging are the combination of different imaging modalities (e.g optical imaging and MRI) and the specific labelling of disease relevant targets. For these reasons, targeted multimodal probes based on nanoparticles are under investigation to be prospectively transferred to the clinics. Depending on the nanoparticle probe composition and size, the vectorization module (like antibodies or smaller target affine molecules), the fluorescent dye, and the orientation of the various modules one to another, different nanoparticle probes with altered suitability for molecular imaging can be synthesized. In our study DY-649-labelled anti-mVCAM-1 antibodies were conjugated via maleimide chemistry to dextran coated ultra small iron oxide nanoparticles. The magneto-optical probes produced in this way are distinctly different from known VCAM-1-targeting multimodal particle based probes [1, 2] and have to be evaluated for their usefulness in multimodal imaging approaches.
Methods

Synthesis of VCAM-1 targeting probes
The synthesis of the VCAM-1 targeting magneto-optical probe was carried out in two steps. First, the hemicyanine fluorescent dye DY-649 (Dyomics) was conjugated as NHS-ester to the antibodies under alkaline conditions (pH 8.0) which addresses amino residues on the antibodies. Briefly, DY-649 was suspended in DMF (~ 20 mM) and added in a 2-6-fold excess to the antibody solution in coupling buffer (100 mM NaHCO 3 , 500 mM NaCl, pH 8.0). The sample was mixed at room temperature and 900 rpm for 2 h. The antibody/DY-649 conjugate was purified from unbound dye by ultrafiltration (cut off: 10 kDa). In the same step, the buffer was changed to PBS pH 7.4. The basis for calculating the antibody/dye ratios were absorption measurements and the law of Lambert-Beer. Secondly, the antibody/dye conjugates were covalently conjugated to superparamagnetic iron oxide nanoparticles with a cross-linked dextran coating (nanomag ® -CLD-spio 20 nm, micromod Partikeltechnologie) and maleimide or PEG-maleimide as functional groups (Fig.1) . In order to not affect the structure of the antibodies, sulfhydryl 
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